Flagship Biosciences
Flagship Biosciences, Leap Therapeutics Partner on Biomarker Screening for DKN-01 Clinical Trial
Flagship will use its RNAscope assay and image analysis to screen advanced gastric and gastroesophageal cancer patients for elevated DKK1 RNA expression.
Gestalt Diagnostics Enters Collaborations on Cancer Pathology Testing
In one of its partnerships, Gestalt will work to integrate Flagship Bioscience's machine learning tools to enable cancer biomarker detection.